Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of VRTX will rise by +2.75% over the next 2 Weeks and hit $468.76 by Friday, January 2, 2026. In that time frame, VRTX's share price is expected to range between $459.24 and $478.56.
BearishAverageBullishVRTX shares rose +0.09% in Monday, December 22, 2025's trading session, rising from a previous close of $456.20 to move at $456.61. The stock demonstrated notable intraday movement (see VRTX's key stats for a full breakdown), fluctuating between $453.03 and $458.71, a +1.25% trading range. While recent weeks have seen some volatility, VRTX has managed to secure a +0.25% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 4.56M shares changing hands, 3.22M more than the previous session. This amounted to $2.08B in total market activity.
Will VRTX Continue Its Upward Trend?
According to analyst ratings and projections for VRTX, Vertex Pharmaceuticals Incorporated shares are anticipated to increase by +4.64%, potentially reaching $478.80 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for VRTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the VRTX stock forecast, now is a good time to buy VRTX stock because its current trading price is -2.59% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on VRTX covering social and institutional perspectives.
VRTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into VRTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 59.63% to 61.55%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 55.11%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.00%, maintains a neutral outlook for the long term. Insights into VRTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Vertex Pharmaceuticals Short-Term Forecasts
VRTX Forecast For Next 5 Days
Our algorithm anticipates Vertex Pharmaceuticals (VRTX) stock could hit $458.78 by Dec 29, 2025. This represents a +0.48% rise from today's price, following a +2.30% change over the past five days.
VRTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Vertex Pharmaceuticals Incorporated (VRTX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $463.48, which would mean a +1.51% increase from the current price of $456.61. Projections for this period range from a high of $481.95 to a low of $441.03.
VRTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Vertex Pharmaceuticals's price over the next three months point to a rise. VRTX stock is expected to peak at $491.31 on Feb 02, 2026 after potentially dipping to $440.31 on Dec 24, 2025. On average, VRTX is likely to trade around $466.39 in the coming 90 days.
Vertex Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Vertex Pharmaceuticals (VRTX) is expected to trade between $440.31 and $478.06 throughout 2025. This would result in an average price of $457.91, potentially offering investors a +0.29% return from current levels.
Vertex Pharmaceuticals Incorporated Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Vertex Pharmaceuticals Incorporated (VRTX) is positioned to show a strong performance in December 2025. The price is predicted to move between $440.31 and $478.06, settling at an average of $457.91. This could translate to a +0.29% gain.
January 2026
Based on current market signals, Vertex Pharmaceuticals Incorporated is projected to trend january 2026. We forecast a trading range from $443.68 to $486.24, with a likely average price of $465.49. Investors could expect a potential return of +1.95%.
February 2026
Our predictive algorithms indicate Vertex Pharmaceuticals Incorporated stock may see a shift in February 2026. The expected range spans $448.44–$491.31, with an average target of $469.20. This represents a positive outlook and a possible gain of +2.76%.
March 2026
Analyzing established trends, Vertex Pharmaceuticals Incorporated looks set to move in March 2026. Projections place the stock between $447.47 and $488.48, averaging around $467.94. This suggests a +2.48% gain from current levels.
April 2026
Market indicators suggest Vertex Pharmaceuticals Incorporated could experience notable changes during April 2026. Prices could fluctuate within $444.32 to $495.85, with a midpoint forecast of $466.64. The stock might deliver a +2.20% gain.
May 2026
Forecasting for May 2026, models estimate that Vertex Pharmaceuticals Incorporated may undergo key fluctuations. If trends hold, the stock might trade between $458.09 and $497.29, averaging $477.82. This signals a positive trajectory with potential returns around +4.65%.
June 2026
According to our latest forecast models, Vertex Pharmaceuticals Incorporated (VRTX) is positioned to show a strong performance in June 2026. The price is predicted to move between $467.61 and $512.23, settling at an average of $487.57. This could translate to a +6.78% gain.
July 2026
Based on current market signals, Vertex Pharmaceuticals Incorporated is projected to trend july 2026. We forecast a trading range from $472.24 to $511.67, with a likely average price of $491.42. Investors could expect a potential return of +7.62%.
August 2026
Our predictive algorithms indicate Vertex Pharmaceuticals Incorporated stock may see a shift in August 2026. The expected range spans $468.31–$509.05, with an average target of $489.22. This represents a positive outlook and a possible gain of +7.14%.
September 2026
Analyzing established trends, Vertex Pharmaceuticals Incorporated looks set to move in September 2026. Projections place the stock between $465.38 and $515.60, averaging around $490.00. This suggests a +7.31% gain from current levels.
October 2026
Market indicators suggest Vertex Pharmaceuticals Incorporated could experience notable changes during October 2026. Prices could fluctuate within $473.12 to $524.01, with a midpoint forecast of $500.38. The stock might deliver a +9.59% gain.
November 2026
Forecasting for November 2026, models estimate that Vertex Pharmaceuticals Incorporated may undergo key fluctuations. If trends hold, the stock might trade between $488.74 and $532.41, averaging $510.61. This signals a positive trajectory with potential returns around +11.83%.
December 2026
According to our latest forecast models, Vertex Pharmaceuticals Incorporated (VRTX) is positioned to show a strong performance in December 2026. The price is predicted to move between $494.34 and $532.55, settling at an average of $512.98. This could translate to a +12.35% gain.
VRTX's history of dividends and stock splits also plays a role in long-term investor confidence.